FR05C0032I1 - - Google Patents

Info

Publication number
FR05C0032I1
FR05C0032I1 FR05C0032C FR05C0032I1 FR 05C0032 I1 FR05C0032 I1 FR 05C0032I1 FR 05C0032 C FR05C0032 C FR 05C0032C FR 05C0032 I1 FR05C0032 I1 FR 05C0032I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24757965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR05C0032(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US1997/013244 external-priority patent/WO1998004569A1/en
Application filed filed Critical
Publication of FR05C0032I1 publication Critical patent/FR05C0032I1/fr
Application granted granted Critical
Publication of FR05C0032I2 publication Critical patent/FR05C0032I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR05C0032C 1996-07-26 2005-07-19 Analogues de nucleotides Active FR05C0032I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68683896A 1996-07-26 1996-07-26
PCT/US1997/013244 WO1998004569A1 (en) 1996-07-26 1997-07-25 Nucleotide analogs

Publications (2)

Publication Number Publication Date
FR05C0032I1 true FR05C0032I1 (ko) 2005-08-26
FR05C0032I2 FR05C0032I2 (fr) 2006-12-29

Family

ID=24757965

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0032C Active FR05C0032I2 (fr) 1996-07-26 2005-07-19 Analogues de nucleotides

Country Status (14)

Country Link
EP (1) EP0915894B1 (ko)
KR (1) KR100619298B1 (ko)
CN (2) CN100384859C (ko)
AT (1) ATE240339T1 (ko)
AU (1) AU713374B2 (ko)
DE (3) DE122005000041I2 (ko)
DK (1) DK0915894T3 (ko)
ES (1) ES2198003T3 (ko)
FR (1) FR05C0032I2 (ko)
HK (1) HK1020964A1 (ko)
LU (2) LU91178I2 (ko)
NL (2) NL300202I1 (ko)
NZ (1) NZ333687A (ko)
PT (1) PT915894E (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396689C (zh) * 2006-03-07 2008-06-25 中国医学科学院医药生物技术研究所 一组具有抑制hiv-1/hbv病毒复制活性的替诺福韦单酯化合物
CN102453055B (zh) * 2010-10-29 2015-04-01 上海迪赛诺医药发展有限公司 制备(r)-9-(2-膦酰甲氧基丙基)腺嘌呤双(异丙氧羰基氧甲基)酯的方法
CN102887901B (zh) * 2011-07-01 2015-01-07 四川好医生攀西药业有限责任公司 无环核苷酸类似物及其制备方法和应用
MX336627B (es) 2011-08-16 2016-01-26 Gilead Sciences Inc Hemifumarato de tenofovir alafenamida.
CN103242366B (zh) * 2012-08-13 2014-08-20 洛阳聚慧投资股份有限公司 一组替诺福韦酯化合物、制备方法及其在抗病毒方面的应用
CN103232490B (zh) * 2013-01-31 2015-06-10 洛阳聚慧投资股份有限公司 具有抑制hiv-1/hbv病毒复制活性的核苷类化合物、制备方法及抗病毒方面的应用
CN104230934B (zh) * 2013-06-08 2016-12-28 上海医药工业研究院 一种化合物及其制备方法和用途
PT2860184T (pt) 2013-10-09 2018-11-20 Zentiva Ks Sal de di-hidrogenofosfato de tenofovir disoproxil
CN104844459B (zh) * 2014-02-18 2016-08-24 扬州三友合成化工有限公司 一种氯甲基异丙基碳酸酯的制备方法
CN103880884A (zh) * 2014-03-21 2014-06-25 浙江苏泊尔制药有限公司 一种高纯度富马酸泰诺福韦酯的制备方法
CN104098605B (zh) * 2014-07-30 2015-09-30 福建广生堂药业股份有限公司 一种适合于工业化生产的替诺福韦制备方法
KR101703257B1 (ko) 2014-09-30 2017-02-06 한미정밀화학주식회사 고순도의 (r)-9-[2-(포스포노메톡시)프로필]아데닌의 제조방법
KR101703258B1 (ko) 2014-12-30 2017-02-06 한미정밀화학주식회사 고순도의 (r)-9-[2-(포스포노메톡시)프로필]아데닌의 제조방법
CN105985381B (zh) * 2014-12-30 2018-10-30 安徽贝克联合制药有限公司 一种替诺福韦的制备方法
KR101761466B1 (ko) * 2015-01-20 2017-07-26 씨제이헬스케어 주식회사 신규한 테노포비어 디소프록실 캠실레이트, 이의 결정형 및 이의 제조방법
CN106349289A (zh) * 2016-08-03 2017-01-25 上海延安药业有限公司 替诺福韦酯原料药及片剂
KR101909570B1 (ko) * 2016-12-05 2018-10-19 (주) 성운파마코피아 고순도 테노포비어 디소프록실 제조방법
CN108358968B (zh) * 2018-04-03 2020-09-15 科兴生物制药股份有限公司 一种替诺福韦的制备方法
KR20220141457A (ko) 2021-04-13 2022-10-20 경동제약 주식회사 신규 결정형의 테노포비어 알라펜아미드 말레산염 및 이를 포함하는 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2111043B (en) * 1980-12-12 1985-02-06 Ciba Geigy Ag Novel cephalosporin esters
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
EP0481214B1 (en) * 1990-09-14 1998-06-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Prodrugs of phosphonates
CA2054126A1 (en) * 1990-10-26 1992-04-27 Michiyuki Sendai Cephem compounds, their production and use
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles

Also Published As

Publication number Publication date
HK1020964A1 (en) 2000-05-26
KR100619298B1 (ko) 2006-09-08
DE122005000041I2 (de) 2012-05-24
NL300202I1 (nl) 2005-09-01
CN1244200A (zh) 2000-02-09
DK0915894T3 (da) 2003-09-15
AU713374B2 (en) 1999-12-02
DE69722004T2 (de) 2004-04-01
CN101239989B (zh) 2012-12-12
ES2198003T3 (es) 2004-01-16
LU91178I9 (ko) 2018-12-28
KR20000029705A (ko) 2000-05-25
CN100384859C (zh) 2008-04-30
ATE240339T1 (de) 2003-05-15
DE122008000033I1 (de) 2008-10-02
PT915894E (pt) 2003-10-31
AU3897097A (en) 1998-02-20
NZ333687A (en) 2000-08-25
EP0915894A1 (en) 1999-05-19
LU91178I2 (fr) 2005-08-22
DE69722004D1 (de) 2003-06-18
LU91433I2 (fr) 2008-06-30
EP0915894B1 (en) 2003-05-14
DE122005000041I1 (de) 2005-10-20
NL300344I1 (nl) 2008-07-01
FR05C0032I2 (fr) 2006-12-29
CN101239989A (zh) 2008-08-13

Similar Documents

Publication Publication Date Title
AR026660A2 (ko)
FR05C0032I1 (ko)
ITMI960248A0 (ko)
ITMI960059A0 (ko)
IN187276B (ko)
ITMI960652V0 (ko)
ITMI960282A0 (ko)
IN189983B (ko)
IN188356B (ko)
ITMI960343A0 (ko)
BR7601346U (ko)
BR7600721U (ko)
ITMI960373A0 (ko)
ITMI960522V0 (ko)
ITMI960592V0 (ko)
CN3047597S (ko)
CN3047249S (ko)
CN3047788S (ko)
CN3047746S (ko)
CN3047648S (ko)
CN3047647S (ko)
CN3047919S (ko)
CN3047496S (ko)
EP0909131A4 (ko)
CN3047495S (ko)